US2015079041A1PendingUtilityA1
Bacterial composition and its use
Est. expiryDec 5, 2022(expired)· nominal 20-yr term from priority
A61P 37/00A61P 37/04A61P 37/02A61P 37/08A61P 29/00A61P 1/00C12N 1/20A61K 35/745A61K 35/747C12R 2001/23C12R 2001/01C12R 2001/25C12R 2001/225C12N 1/205
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
Claims
exact text as granted — not AI-modified1 - 21 . (canceled)
22 . A method for modulating the immune system of a human or animal in need thereof, said method comprising the step of administering to said human or animal in need thereof an effective amount of a bacterial composition comprising Bifidobacterium bifidum PTA-4801.
23 . The method according to claim 22 , wherein said method is a method for stimulating the immune system of a human or an animal in need thereof.
24 . The method according to claim 22 , wherein said bacterial composition further comprises at least one additional strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus paracasei PTA-4800, Bifidobacterium lactis PTA-4802.
25 . The method according to claim 22 , wherein said bacterial composition further comprises at least two additional strains selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus paracasei PTA-4800, Bifidobacterium lactis PTA-4802.
26 . The method according to claim 22 , wherein said bacterial composition comprises a blend of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus paracasei PTA-4800, Bifidobacterium lactis PTA-4802.
27 . The method according to claim 22 , wherein said bacterial composition comprises from 10 6 to 10 11 CFU of bacteria/g of composition.
28 . The method according to claim 22 , wherein said bacterial composition comprises from 10 8 to 10 11 CFU of bacteria/g of composition.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.